Erica K. Evans
Erica K. Evans publishes mostly in Molecular Biology, Oncology and Immunology, on topics such as Mast cells and histamine, Lung Cancer Treatments and Mutations and Chronic Lymphocytic Leukemia Research.
- World rank
- #1,215,804 of 7,710,434 ranked researchers
- Rank in United States
- #389,487 of 1,627,098
- Works
- 85
- Citations
- 3k
- Citations per work
- 35.3
What does Erica K. Evans research?
Erica K. Evans's work is mostly in Medicine (38%), Biochemistry, Genetics and Molecular Biology (14%), Immunology and Microbiology (11%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3238.0%
- Medicine3238.0%
- Everything else3136.9%
- Life Sciences2125.1%
- 1Molecular Biology14% of their works
- 2Oncology13% of their works
- 3Immunology11% of their works
- 4Hematology10% of their works
- 5Pulmonary and Respiratory Medicine9% of their works
- 6Genetics7% of their works
Research topics
Which keywords describe Erica K. Evans's research?
The keywords of their largest research topics: Prognostic Factors, Imatinib Mesylate, Allergic Disease, EGFR Mutations, Mast Cells, Targeted Therapy, Chronic Lymphocytic Leukemia and Genomic Aberrations.
- International Myeloma Working Group
- Fusion Genes
- Therapeutic Antibodies
- PDGFRA Mutations
- p53
- Genomic Aberrations
- Targeted Therapy
- EGFR Mutations
- Imatinib Mesylate
- Prognostic Factors
- Allergic Disease
- Mast Cells
- Chronic Lymphocytic Leukemia
- Cell Cycle
- Fc Receptors
- Sunitinib
- Diagnosis Criteria
- Hypereosinophilic Syndrome
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Prognostic Factors152 topics
- Imatinib Mesylate112 topics
- Allergic Disease101 topic
- EGFR Mutations101 topic
- Mast Cells101 topic
- Targeted Therapy101 topic
- Chronic Lymphocytic Leukemia91 topic
- Genomic Aberrations91 topic
- Cell Cycle81 topic
- p5381 topic
- Fc Receptors61 topic
- PDGFRA Mutations61 topic
- Sunitinib61 topic
- Therapeutic Antibodies61 topic
- Diagnosis Criteria51 topic
- Fusion Genes51 topic
- Hypereosinophilic Syndrome51 topic
- International Myeloma Working Group51 topic
Where does Erica K. Evans work?
Erica K. Evans's main affiliation in the publication record is Blueprint Medicines (United States), United States.
How many publications and citations does Erica K. Evans have?
OpenAlex counts 85 works and 3,003 citations for Erica K. Evans, an h-index of 23, ranking #1,215,804 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Erica K. Evans. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.